Viewing Opinion | StockChase
Amgen Inc. (AMGN-Q) opinion on 2004-07-16

Last Price Recorded: 169.9600 on 2017-11-23

ON STOCKCHASE SINCE Oct 2000

biotechnology/pharmaceutical
TOP PICK

Alan Blake
Amgen Inc. was $55.730 at time of opinion
Owned : Yes

Under a cloud. Driven down because of generic drugs and imports from Canada. Medicare will be onerous. Powerful balance sheet.
SELECTIVE

All opinions for AMGN-Q (92)

19 BUY
5 BUY on WEAKNESS
13 COMMENT
8 DON'T BUY
8 HOLD
12 PAST TOP PICK
2 SELL
22 TOP PICK
1 WAIT
1 WATCH
1 WEAK BUY
View All

More experts covering AMGN-Q

SAVE
Add AMGN-Q to Watch List

All opinions for AMGN-Q (92)

19 BUY
5 BUY on WEAKNESS
13 COMMENT
8 DON'T BUY
8 HOLD
12 PAST TOP PICK
2 SELL
22 TOP PICK
1 WAIT
1 WATCH
1 WEAK BUY
View All

More experts covering AMGN-Q

SAVE
Add AMGN-Q to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company